Pamela Anderson said at amfAR’s gala in Venice that a hepatitis C diagnosis in the late 1990s upended her life, cost her everything in her bank account and still has not fully stopped hurting. Honored with amfAR’s Award of Courage on Sunday night, she said she was hep C free by 2015 after years of living with what she described as a death sentence.
That is why the Pamela Anderson Hepatitis C story is drawing attention now: she was speaking publicly about the disease, the fear it created and the price of getting well at an event built around biomedical research and advocacy. The gala was held at the Hilton Molino Stucky, hosted by Taika Waititi, and helped raise $3 million for amfAR’s biomedical research programs.
Anderson said the diagnosis did not just affect her health. It changed how she made decisions, left her worried about what might happen to her young children and turned her life inside out. She said a doctor told her there was no cure at the time and that she probably had about 10 years to live, a message that she said colored and corrupted her choices for years.
The part that lingers is that her recovery did not erase the damage the diagnosis did to her sense of self. Anderson said she still has not fully recovered from hearing the news, even though she later came to terms with it and says her truth has come through her work. Her recent career resurgence has included roles in The Last Showgirl, The Naked Gun, Rosebush Pruning and Place to Be, but in Venice she framed the larger story as one of survival rather than reinvention.
She said shame and guilt stayed with her, and that the illness felt carved into her forehead. That is the contradiction at the heart of her account: she calls herself a victor, not a victim, yet the diagnosis still appears to shadow the way she remembers that period of her life. The unresolved question is not whether she survived hepatitis C. It is how long it took for survival to feel like recovery, and what treatment actually carried her there.
The night also put her story beside amfAR’s broader mission, which includes work tied to HIV/AIDS and hepatitis C research. But Anderson’s words were the center of the room. She described a disease that once seemed to promise an ending and a recovery that, even now, she says she is still learning to absorb.
